If you liked this article you might like

Stocks on Track for Fresh Records as Health Care Sector Climbs
Biogen Shares Up Following Eli Lilly's Failed Alzheimer's Study
Jim Cramer -- Be Careful With Biogen; Apple Is Waking Up
Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results